Here we are at the midpoint of 2016 already. Time to look back on the past six months—and some of the top stories of the year so far.
The following represent a cross-section of what Xconomy offers on a daily basis:... Read more »
Vice president, chief strategy and operating officer of the Texas Medical Center
CEO and Founder, Techstars
Nobel Laureate, Professor of Biology, Caltech
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
[Corrected 6/30/16, 2:49 p.m. See below.] Google Capital’s $46.35 million investment in publicly traded Care.com, announced Wednesday, marked a departure from the firm’s usual bets on late-stage private companies and illustrated how the traditional lines in the venture capital... Read more »
Roboticists covered a sweeping range of topics at Xconomy’s annual Robo Madness West conference last week, from the ethics of artificial intelligence to the powerful impact of robots that have faces.
Two themes ran through all the panel discussions, whether they... Read more »
Moderna Therapeutics still hasn’t produced data in humans supporting its technology, which is meant to turn our bodies into little drugmaking factories. But the Cambridge, MA-based company nonetheless keeps grabbing the attention, and cash, of other drugmakers.
Moderna said today that... Read more »
The Boston-area cybersecurity scene is ripe with acquisition targets. IBM bought incident-response firm Resilient Systems earlier this year. Now, Cisco Systems says it is acquiring CloudLock, a Waltham, MA-based cloud security company, for $293 million in cash and stock, plus... Read more »
Just another billion-dollar exit for a Massachusetts company most people have never heard of. This one has an interesting backstory, in a field rife with consolidation and would-be deals.
Consumer tech giant Apple, which has spent considerable effort positioning its products as health and fitness helpers, has just hired someone who knows Big Pharma and Big Data. Stephen Friend, a veteran of drug R&D and, more recently, a nonprofit effort... Read more »
Venture investors, as well as tech companies hesitant to try going public, were hanging on the outcome of communications software company Twilio’s IPO this week in hopes that it would signal a thaw in the mood on Wall Street for such... Read more »
Google Fiber plans to acquire Webpass in a deal that trims the ranks of independent Internet service providers—an industry already maligned for its lack of competition—but ultimately could boost consumer access to high-speed Internet.
San Francisco-based Webpass has spent the past... Read more »
Twilio, a Web communications company reportedly valued at more than $1 billion after a financing last year, raised $150 million in its initial public offering today, according to a press release.
The San Francisco-based company sold 10 million shares for... Read more »
LightCyber, a cybersecurity company that specializes in detecting hackers once they’ve breached the outer defenses of a data network, announced today it raised $20 million in a Series B financing round.
The venture round was led by Claltech, an Israeli... Read more »
Because public investors have had a more discerning attitude toward biotech IPOs this year, insiders have had to step up to help their companies go public. One extreme example is Selecta Biosciences, which just priced its offering late Tuesday with its... Read more »
Radicle, a new accelerator fund focused on agricultural ventures, is launching today with plans to seed and nurture the next generation of agtech companies addressing global farming problems.
The new accelerator will have locations in multiple states and around the world.... Read more »
[Updated, 6/21/16, 5:40pm. See below.] Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with a... Read more »
[Corrected, 6/21/06, 10:49 am. See below.] Internet billionaire Sean Parker’s new cancer immunotherapy institute didn’t waste time putting its $250 million to use in unexpected ways.
The San Francisco-based institute, part of a massive philanthropic effort by former Facebook... Read more »
In 2011, Margaret Hall, co-founder and national executive director of the GreenLight Fund, first made contact with social entrepreneurs in Detroit. She wanted to discuss the idea of her philanthropic venture fund, which invests in nonprofit entities rather than startups,... Read more »
Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. Data from a hematology conference stoked dreams of approval, though still on a far horizon, for a couple drug makers. Long anticipated, Walgreens officially cut ties with... Read more »
If you’ve been rambling around Second Street in San Francisco’s South of Market tech hub recently (shown here), you might have seen an unusual sight—-a tall young Australian walking along with an open laptop connected to a mysterious knobby white stick.... Read more »
FICO, the San Jose, CA, software analytics company, announced Tuesday it has acquired Ann Arbor, MI-based QuadMetrics, a University of Michigan cybersecurity spinout. The terms of the deal were not disclosed.
FICO—known as an industry leader in measuring and... Read more »
Mylestoned, a young Boston startup aiming to develop a more interactive and meaningful way of digitally memorializing the dead, has acquired the photo-scanning technology of Heirloom, a small San Francisco firm.
We’re all always watching out for those new companies whose innovations turn out to be the gateway for systemic change across many tech sectors, as early mobile devices and cloud computing services did.
Infinity Pharmaceuticals got a new lease on life in 2014 when pharma giant AbbVie plunked down $275 million to see if the company’s blood cancer drug, duvelisib, could stand out in a crowded field. The answer came back negative today, and... Read more »
Microsoft will acquire LinkedIn in a $26.2 billion cash deal that bolsters the tech giant’s offerings for professionals and shrinks the ranks of the major independent social networks.
If you blinked, you probably missed something this week in biotech. The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San Francisco. In Boston, there were more twists for a closely... Read more »
Partner, Morgenthaler Ventures
President and CEO, BayBio
Partner, Venrock Ventures
Fellow, American Association for Artificial Intelligence
CEO, i-Human Patients.
President and CEO, Complete Genomics
Professor of Biomolecular Engineering, UC Santa Cruz
Executive Director, Center for Open Innovation, UC Berkeley
Former SVP of Discovery Research, Amgen
Director, Energy Biosciences Inst., UC Berkeley